Indefinite Delivery Contract 75N91022D00003
Award Date
7/1/22
Last Date to Order
6/30/27
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health National Cancer Institute awarded a single-award indefinite delivery contract to American Type Culture Collection to provide field and biospecimen support services. The contract has a potential value of $320 million and a period of performance from July 2022 to June 2027, with an option for additional task orders through June 2032. The contractor will perform services under five task areas to support the Division of Cancer Epidemiology and Genetics ongoing...
The National Cancer Institute's Division of Cancer Epidemiology and Genetics (DCEG) awarded a single-award Indefinite Delivery Contract (IDC) valued up to $320 million to ICF Incorporated, L.L.C. to provide field preparation, biospecimen collection, clinical activities, and other support services for DCEG's epidemiology and genetic research programs through June 2027. The contract has five primary task areas: (A) transition services, (B) field study management and support, (C) biospecimen...
The National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), has awarded a single-award Indefinite Delivery Contract (IDC) to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp. The $320 million contract provides field and biospecimen support services for the NCI's Division of Cancer Epidemiology and Genetics (DCEG) through June 2027. Under this IDC, Social & Scientific Systems has been issued a $5,121,958 delivery order for...
The National Institutes of Health National Cancer Institute awarded an indefinite delivery contract to Information Management Services, Inc. for biomedical information management and analytic support services with a potential value of $148 million. Under the contract vehicle, three task orders have been awarded to date for data infrastructure support, data management and preparation services, and advanced statistical and bioinformatics analysis for various cancer research studies. Task order...
The National Institutes of Health National Cancer Institute awarded an indefinite delivery indefinite quantity multiple award contract with a potential value of $148 million to provide biomedical information management and analytic support services. Task areas under the contract include data modeling, acquisition and management; data analysis, statistical and bioinformatics analysis and tool development; and general program support. Two task orders have been issued against this contract. The...
The National Cancer Institute awarded a single-award indefinite delivery contract to the Arkansas Department of Health to support the Surveillance, Epidemiology, and End Results Program. The contract has a potential value of $500 million over an eight-year period of performance from May 2021 through April 2028. Under the contract, the prime contractor will collect and report cancer incidence, treatment, and survival data as part of SEER. Data will be managed through the SEER*DMS system and cover...
The National Cancer Institute awarded a single-award, indefinite delivery contract valued up to $500 million to the Tennessee Department of Health, Division of Fiscal Services as the prime contractor. The contract supports the Surveillance Epidemiology and End Results program through the collection and management of cancer incidence, treatment, and survival data. A $49.5k firm fixed price delivery order was issued against the contract for registry linkages and data management from September 2023...
The Department of Health and Human Services (HHS) National Cancer Institute (NCI) has awarded Westat, Inc., a for-profit professional services firm, a $320 million multiple-award Indefinite Delivery Contract (IDC) to provide comprehensive field and biospecimen support services for the Division of Cancer Epidemiology and Genetics (DCEG). This 10-year contract, with a period of performance from July 2022 to June 2027, will enable NCI to issue task orders to Westat for a wide range of services,...
The National Cancer Institute awarded multiple indefinite delivery indefinite quantity contracts under the Biomedical Information Management and Analytic Support Services master contract to provide data modeling, acquisition, management, analytics, statistical analysis, bioinformatics support, and software/tool development services. Westat, Inc. received an award with a potential value of $148 million to be issued against task orders over a five-year base period ending in September 2025....
The National Cancer Institute (NCI), part of the National Institutes of Health within the Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Azenta US Inc., doing business as Brooks Life Sciences Inc., for the provision of genomic characterization services to support the NCI's Center for Cancer Genomics research programs. The IDIQ contract has a $49,832,452 ceiling value and a period of performance from August 31, 2019 through...